A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Islam, Saidul
مؤلفون آخرون:	Sharmin, Shahana
التنسيق:	أطروحة
اللغة:	English
منشور في:	Brac University 2022
الموضوعات:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
الوصول للمادة أونلاين:	http://hdl.handle.net/10361/17308

مواد مشابهة

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
بواسطة: Karim, Azrin
منشور في: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
بواسطة: Flora, Sanzida Alam
منشور في: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
بواسطة: Meem, Manila
منشور في: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
بواسطة: Alam, Tahera
منشور في: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
بواسطة: Jahan, Nusrat
منشور في: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
بواسطة: Ahmed, Nafisa
منشور في: (2023)

Immunotherapy in the Management of Lung Cancer
بواسطة: Tasnim, Humayra
منشور في: (2022)

A review on triple-negative breast cancer and its potential treatment
بواسطة: Niasa, Jannatul Ferdous
منشور في: (2023)

Stem cells as therapeutic carrier in cancer treatment
بواسطة: Anika, Mysha Yeasmin
منشور في: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
بواسطة: Hasan, Amit
منشور في: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
بواسطة: Chakraborty, Anuradha
منشور في: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
بواسطة: Khan, Muidul Hasan
منشور في: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
بواسطة: Roy, Hredita
منشور في: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
بواسطة: Emon, Kamrul Hasan
منشور في: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
بواسطة: Mirza, Maisa Tasnim
منشور في: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
بواسطة: Khan, Rezia Nowrin
منشور في: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
بواسطة: Nuha, Nabiha Tahsin
منشور في: (2024)

Role of statins as antagonists of SPARC in gastric cancer
بواسطة: Shahmat, Rad
منشور في: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
بواسطة: Sorno, Rubina Haque
منشور في: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
بواسطة: Ratu, Tabassum
منشور في: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
بواسطة: Choki, Kinley
منشور في: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
بواسطة: Razna, Amrin Islam
منشور في: (2019)

A comprehensive review on drug repurposing in cancer treatment
بواسطة: Sarkar, Onusree
منشور في: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
بواسطة: Mahaleka, Aarshi
منشور في: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
بواسطة: Shaikat, Mahdi Mubin
منشور في: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
بواسطة: Hasan, Sakib
منشور في: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
بواسطة: Nawar, Anika
منشور في: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
بواسطة: Deeba, Maliha Tasnim
منشور في: (2018)

Targeting BRAFV600E in the treatment of CRC
بواسطة: Roja, Mashwiyat Samrin
منشور في: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
بواسطة: Alam, Kazi Tasnuva
منشور في: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
بواسطة: Rahman, Sanjida
منشور في: (2024)

Biosimilar in lymphoma treatment
بواسطة: Tanisha, Mehrin Haque
منشور في: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
بواسطة: Khondokar, Faiza
منشور في: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
بواسطة: Islam, Nahidul
منشور في: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
بواسطة: Beruni, Sajid Mahmud Al
منشور في: (2022)

Oncogenes: new targets in cancer treatment
بواسطة: Chowdhury, Waseka Shams
منشور في: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
بواسطة: Muntaha, Habibatul
منشور في: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
بواسطة: Haque, Mushfiqul
منشور في: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
بواسطة: Karim, Samia Binte
منشور في: (2024)